Skip to main navigation
Release Details
A recording of the event will be available at7:00am ET on September 11, 2023 on the investor relations section of MedAvail’s website at https://investors.medavail.com and will be archived for 90 days.
About MedAvail
MedAvail promotes patient drug adherence, resulting in better health outcomes. Learn more at www.medavail.com.
Contacts:
Steven Halper /Caroline Paul LifeSci Advisors
Investor Relations
Managing Directors,
ir@medavail.com
SOURCEMedAvail Holdings, Inc.
Source: MedAvail Holdings, Inc.
1.877.830.0826
info@medavail.com
ir@medavail.com
Home office:
4720 E. Cotton Gin Loop
Suite 220
Phoenix, AZ 85040
Canada office:
6665 Millcreek Dr. Unit 1
Mississauga, ON L5N 5M4 Canada
Sorry. You must be logged in to view this form.
Footer Nav 2
© 2023 MedAvail Technologies, Inc. All rights reserved.